Altimmune (ALT) Revenue (2010 - 2025)
Altimmune's (ALT) quarterly Revenue came in at $26000.0 in Q4 2025, up 420.0% year-on-year from $5000.0 in Q4 2024, and up 420.0% on a QoQ basis from $5000.0 in Q3 2025.
Altimmune (ALT) Revenue (2010 - 2025) Analysis & Trends
Altimmune (ALT) has 16 years of Revenue data on file, last reported at $26000.0 in Q4 2025.
- On a quarterly basis, Revenue rose 420.0% year-over-year to $26000.0 in Q4 2025; TTM through Dec 2025 was $41000.0, a 105.0% increase from a year earlier, with the FY2025 full-year figure at $41000.0, up 105.0% from the prior year.
- Revenue for Q4 2025 stood at $26000.0, up from $5000.0 in the prior quarter.
- Over the last five years, Revenue for ALT reached as high as $3.3 million in Q4 2021 and fell as low as $2000.0 in Q3 2022.
- Historically, Revenue has averaged $248250.0 across 5 years, with a median of $14500.0 in 2022.
- Across the five-year window, Revenue sank 99.21% in 2022 and surged 18000.0% in 2023, its largest moves.
- Year by year, Revenue stood at $3.3 million in 2021, then sank by 99.21% to $26000.0 in 2022, then jumped by 42.31% to $37000.0 in 2023, then slumped by 86.49% to $5000.0 in 2024, then surged by 420.0% to $26000.0 in 2025.
- Per Business Quant data, the three most recent Revenue figures were $26000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Altimmune | 346.63 Mn | 346.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 362,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 3.28 Mn |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 137,000.00 |
| Mar 31, 2021 | 838,000.00 |